Luca Testa retweeted
EBC-MAIN did not meet the superiority goal in the context of lower than anticipated events and treatment effect in the control arm, which are two conditions that may have shifted the results towards neutrality. Several differences exist between the EBC-MAIN and DK-CRUSH V trials.
Luca Testa retweeted
Transcatheter Aortic Valve Replacement for Degenerated Transcatheter Aortic Valves: The TRANSIT International Project, by Testa et al
ahajournals.org/doi/10.1161/…
@DrLucaTesta @azeemlatib @GGStefanini
Luca Testa retweeted
Wow...MIND BLOWN!
Transcatheter Aortic Valve Implantation (TAVI) inside a degenerate MECHANICAL valve!
Published in EHJ Case Reports...
Luca Testa retweeted
Se il capogruppo alla Camera del primo partito (secondo i sondaggi) contribuisce in maniera così dannosa ed esplicita alla disinformazione è inutile continuare a scrivere tweet per spiegarvi come stanno davvero le cose. Il virus vince, ma per nostro autogol volontario.
Replying to @FrancescoLollo1
@FrancescoLollo1 di @FratellidItalia oggi su Repubblica sconsiglia a chi è sotto i 40 anni di vaccinarsi perché “le vaccinazioni non garantiscono dall’infezione”. Parole gravi e irresponsabili. #COVID19
Luca Testa retweeted
Don't miss the brand new issue of #MinervaCardiologyAngiology, including seminal works from @tmuenzel, @Fabri84Dascenzo, @DrLucaTesta, @jgchiabrando1, @AbbateAntonio, @FrancescoPaneni, and @giovannilandoni
minervamedica.it/en/journals…
Luca Testa retweeted
Data from NOTION trial show no significant differences in the risk for all-cause mortality in patients with severe aortic valve stenosis randomized to TAVI or SAVR!
#aortic #stenosis #TAVI #cardiotwitter #EHJ @escardio @ESC_Journals
ow.ly/8WGG50FjLnw
Luca Testa retweeted
These both were really challenging cases in patients with poor LV function - and randomized. This trial will truly test whether Impella CP mechanical circulatory support during high-risk PCI is safe and improves long-term outcomes.
Congrats to Amir Kaki (Ascension St John) and Bill O’Neill (Henry Ford) for enrolling the first 2 patients (in that order) in PROTECT IV, the largest RCT ever in patients with ischemic HFrEF receiving HRPCI revascularization. @GreggWStone @coconnormd @DrAmirKaki @BillONeillMD
Luca Testa retweeted
Ecco un utile schema riepilogativo delle varianti SARS-CoV-2/COVID (fonte #MinisteroDellaSalute)
PS
Variant Of Concern (VOC) è peggio di Variant Of Interest (VOI)...
Luca Testa retweeted
"In China, the rise in mean BMI among the adult population appears to have slowed down over the past decade. However, we found divergent trends by sex, geographical area, and socioeconomic status"
sciencedirect.com/science/ar…
Luca Testa retweeted
"The total number of retracted systematic reviews is increasing worldwide, in particular in China. Most common reasons for retraction are fraudulent peer-review and unreliable data"
jclinepi.com/article/S0895-4…
Luca Testa retweeted
Guess who is the real secret of #MinervaCardiologyAngiology success (including the recent increase in impact factor, now 1.3)?
The editorial office team led by Laura Fissore and Federica Lombardo!
Please join us in thanking them for all their hard work!
minervamedica.it/en/journals…
The end of an Era?
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial thelancet.com/journals/lance…
Luca Testa retweeted
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Discover more in EHJ! ow.ly/y7Ib50FieIi
#prediction #SCORE2 #risk #primaryprevention #cardiotwitter @escardio @ESC_Journals
Luca Testa retweeted
Paper claimed 650,000 deaths annually from e-cigarettes. Passed peer review. Now retracted. Says a lot about the journal and its peer review process. tobaccocontrol.bmj.com/conte…





























